Literature DB >> 18942563

The psychosocial effects of cancer-related lymphedema.

Anna Towers1, Franco A Carnevale, Mary Ellen Baker.   

Abstract

Life-long lymphedema is a common complication of cancer therapy. In this Canadian study, we adopted a phenomenological methodology to explore the experience of patients with cancer-related lymphedema, and their spouses. We conducted audio taped semistructured interviews with 11 patients and eight spouses, who were recruited through a university hospital-based lymphedema clinic and through local lymphedema therapists. We developed an analytical framework from the data themselves, and tentative hypotheses and thematic categories that represented shared case features. Participants expressed frustration because of lack of financial support from government and insurance companies, inadequate knowledge and perceived lack of interest on the part of physicians, and lack of awareness in society in general. This study suggests further investigation of the funding of lymphedema treatments, and of the effect of lymphedema on work, intimacy, and leisure activities. Our research findings will inform educational initiatives and cancer rehabilitation programs.

Entities:  

Mesh:

Year:  2008        PMID: 18942563

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  10 in total

Review 1.  Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011.

Authors:  Mei R Fu; Sheila H Ridner; Sophia H Hu; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  Psychooncology       Date:  2012-10-09       Impact factor: 3.894

2.  The effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot study.

Authors:  Chiara Singh; Mary De Vera; Kristin L Campbell
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

3.  Lymphedema in Canada: a qualitative study to help develop a clinical, research, and education strategy.

Authors:  P Hodgson; A Towers; D H Keast; A Kennedy; R Pritzker; J Allen
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

4.  How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia.

Authors:  Judith A Meiklejohn; Kristiann C Heesch; Monika Janda; Sandra C Hayes
Journal:  Support Care Cancer       Date:  2012-07-18       Impact factor: 3.603

5.  The challenges of managing complex lymphoedema/chronic oedema in the UK and Canada.

Authors:  Philip A Morgan; Susie Murray; Christine J Moffatt; Amanda Honnor
Journal:  Int Wound J       Date:  2011-08-17       Impact factor: 3.315

6.  Lower limb lymphedema in gynecological cancer survivors--effect on daily life functioning.

Authors:  Gail Dunberger; Helene Lindquist; Ann-Charlotte Waldenström; Tommy Nyberg; Gunnar Steineck; Elisabeth Åvall-Lundqvist
Journal:  Support Care Cancer       Date:  2013-06-29       Impact factor: 3.603

7.  The effect of yoga on women with secondary arm lymphoedema from breast cancer treatment.

Authors:  Annette Loudon; Tony Barnett; Neil Piller; Maarten A Immink; Denis Visentin; Andrew D Williams
Journal:  BMC Complement Altern Med       Date:  2012-05-28       Impact factor: 3.659

8.  Efficacy of complete decongestive therapy (CDT) on edematous rat limb after lymphadenectomy demonstrated by real time lymphatic fluid tracing.

Authors:  Yukari Takeno; Hiromi Arita; Etsuko Fujimoto
Journal:  Springerplus       Date:  2013-05-16

9.  Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study.

Authors:  Afaf Girgis; Fiona Stacey; Teresa Lee; Deborah Black; Sharon Kilbreath
Journal:  BMJ       Date:  2011-06-21

10.  Effects of phase I complex decongestive physiotherapy on physical functions and depression levels in breast cancer related lymph edema.

Authors:  Orçin Telli Atalay; Anıl Özkir; Bilge Başakçi Çalik; Emre Baskan; Harun Taşkin
Journal:  J Phys Ther Sci       Date:  2015-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.